Adjuvant growth hormone therapy in antagonist protocol in poor responders undergoing assisted reproductive technology
Purpose The incidence of poor ovarian response in controlled ovarian stimulation (COH)
has been reported in 9–24% of IVF-ET cycles. Growth hormone augments the effect of …
has been reported in 9–24% of IVF-ET cycles. Growth hormone augments the effect of …
Adjuvant growth hormone therapy in antagonist protocol in poor responders undergoing assisted reproductive technology
M Eftekhar, A Aflatoonian, F Mohammadian, T Eftekhar - 2013 - pubmed.ncbi.nlm.nih.gov
Purpose The incidence of poor ovarian response in controlled ovarian stimulation (COH)
has been reported in 9-24% of IVF-ET cycles. Growth hormone augments the effect of …
has been reported in 9-24% of IVF-ET cycles. Growth hormone augments the effect of …
Adjuvant growth hormone therapy in antagonist protocol in poor responders undergoing assisted reproductive technology.
M Eftekhar, A Aflatoonian… - … of Gynecology & …, 2013 - search.ebscohost.com
Purpose: The incidence of poor ovarian response in controlled ovarian stimulation (COH)
has been reported in 9-24% of IVF-ET cycles. Growth hormone augments the effect of …
has been reported in 9-24% of IVF-ET cycles. Growth hormone augments the effect of …
Adjuvant growth hormone therapy in antagonist protocol in poor responders undergoing assisted reproductive technology
M Eftekhar, A Aflatoonian, F Mohammadian… - Archives of Gynecology …, 2013 - infona.pl
Purpose The incidence of poor ovarian response in controlled ovarian stimulation (COH)
has been reported in 9–24% of IVF-ET cycles. Growth hormone augments the effect of …
has been reported in 9–24% of IVF-ET cycles. Growth hormone augments the effect of …
Adjuvant growth hormone therapy in antagonist protocol in poor responders undergoing assisted reproductive technology.
M Eftekhar, A Aflatoonian, F Mohammadian… - … of Gynecology and …, 2012 - europepmc.org
Purpose The incidence of poor ovarian response in controlled ovarian stimulation (COH)
has been reported in 9-24% of IVF-ET cycles. Growth hormone augments the effect of …
has been reported in 9-24% of IVF-ET cycles. Growth hormone augments the effect of …
Adjuvant growth hormone therapy in antagonist protocol in poor responders undergoing assisted reproductive technology
M Eftekhar, A Aflatoonian… - … of Gynecology and …, 2013 - search.proquest.com
Purpose The incidence of poor ovarian response in controlled ovarian stimulation (COH)
has been reported in 9–24% of IVF-ET cycles. Growth hormone augments the effect of …
has been reported in 9–24% of IVF-ET cycles. Growth hormone augments the effect of …
Adjuvant growth hormone therapy in antagonist protocol in poor responders undergoing assisted reproductive technology.
M Eftekhar, A Aflatoonian… - … of Gynecology & …, 2013 - search.ebscohost.com
Purpose: The incidence of poor ovarian response in controlled ovarian stimulation (COH)
has been reported in 9-24% of IVF-ET cycles. Growth hormone augments the effect of …
has been reported in 9-24% of IVF-ET cycles. Growth hormone augments the effect of …